企業プロフィール
Sonoma Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- SNOA
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
1.34 USD (0.00%)
終値
最終更新: 2026年8月21日
4.03M USD
時価総額
株価変動の要因
As of Aug 21, 2026, SNOA was little changed and closed at $1.34. No new same-company headline was identified in the current news window.
企業概要
Hypochlorous Acid Medical Products
Sonoma Pharmaceuticals develops and manufactures stabilized hypochlorous acid products for wound care, eye care, nasal care, oral care, dermatology, podiatry, animal health, and non-toxic disinfection.
Microcyn Technology
The company’s Microcyn technology produces safe and stable HOCl formulations. The products are intended to reduce itching, pain, scarring, and irritation without damaging healthy tissue and are used in applications including minor abrasions, cuts, and intact-skin management.
Broad End-Market Portfolio
Sonoma adapts the same stabilized HOCl technology across human and animal healthcare. This creates a product portfolio serving wound care, dermatology, eye and nasal care, oral care, podiatry, animal health, and non-toxic disinfection.
Global Commercial Network
Sonoma products are sold directly or through partners in more than 55 countries. The company has recently expanded its U.S. product lineup and channel relationships, including the manufacture of a new HOCl wound cleanser for Medline.
今後のカタリスト
- Sonoma’s catalysts are wound-care and skin-health product demand, along with any update that clarifies the commercial path. The business moves on product adoption.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。